TORPENZ

NDC 0245-0825 · Upsher-Smith Laboratories, LLC

Generic nameEverolimus

Dosage formTABLET

RouteORAL

Active ingredient(s)EVEROLIMUS

Strength10 mg/1

Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]

Marketing categoryANDA

Packages

0245-0825-04 — 28 BLISTER PACK in 1 CARTON (0245-0825-04) / 1 TABLET in 1 BLISTER PACK (0245-0825-89)

0245-0825-30 — 30 TABLET in 1 BOTTLE (0245-0825-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0078-0626 — everolimus, 0078-0627 — everolimus, 0078-0628 — everolimus, 0093-7766 — Everolimus, 0093-7767 — Everolimus, 0093-7768 — Everolimus, 0093-7769 — Everolimus, 0245-0822 — Everolimus, 0245-0823 — Everolimus, 0245-0824 — Everolimus, 49884-158 — Everolimus, 49884-159 — Everolimus, 49884-160 — Everolimus, 49884-283 — Everolimus, 51991-379 — Everolimus tablets, 51991-380 — Everolimus tablets, 51991-381 — Everolimus tablets, 51991-821 — Everolimus, 51991-822 — Everolimus, 51991-823 — Everolimus, +63 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources